| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SUPERNUS PHARMACEUTICALS INC COM | 538,241 | 13,591,000 | 12.52% | ||
| 2 | ANIKA THERAPEUTICS INC COM | 175,967 | 8,615,000 | 7.94% | ||
| 3 | CARDINAL HEALTH INC | 117,800 | 8,478,000 | 7.81% | ||
| 4 | CHARLES RIV LABS INTL INC | 111,112 | 8,466,000 | 7.80% | ||
| 5 | CENCORA | 107,000 | 8,366,000 | 7.71% | ||
| 6 | TARO PHARMACEUTICAL INDS LTD | 78,905 | 8,306,000 | 7.65% | ||
| 7 | ANTHEM INC | 56,300 | 8,094,000 | 7.46% | ||
| 8 | GILEAD SCIENCES INC | 113,000 | 8,092,000 | 7.46% | ||
| 9 | MERCK & CO INC | 136,100 | 8,012,000 | 7.38% | ||
| 10 | MCKESSON CORP | 57,000 | 8,006,000 | 7.38% | ||
| 11 | TRIPLE S MGMT CORP CL B | 364,156 | 7,538,000 | 6.95% | ||
| 12 | SYNERON MEDICAL LTD ORD SHS | 706,107 | 5,931,000 | 5.46% | ||
| 13 | GNC HLDGS INC | 422,955 | 4,669,000 | 4.30% | ||
| 14 | ALPHATEC HOLDINGS INC | 426,855 | 1,370,000 | 1.26% | ||
| 15 | IMMUCELL CORP | 168,323 | 1,002,000 | 0.92% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-000393, filed 2017.01.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
